Who owns the RESVERATROL MAX HX trademark?

The RESVERATROL MAX HX trademark is owned by Invite Health, Inc..

What class is the RESVERATROL MAX HX trademark registered in?

The RESVERATROL MAX HX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RESVERATROL MAX HX?

The USPTO serial number for RESVERATROL MAX HX is 90278183.

What is the registration number for RESVERATROL MAX HX?

RESVERATROL MAX HX is registered under USPTO registration number 6495134.

RES

USPTO Trademark Record

REGISTERED

RESVERATROL MAX HX

SN 90278183·Reg 6495134·Filed Oct 26, 2020

Owner Invite Health, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RESVERATROL MAX HX (Serial No. 90278183), Registration No. 6495134, is a registered US trademark filed on Oct 26, 2020 by Invite Health, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Renewal window: September 21, 2027350 days remaining

Mark Intelligence

RESVERATROL MAX HX (Reg. #6495134) is a registered US trademark that has been protecting its owner, Invite Health, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 26, 2020

SERIAL

90278183

REG#

6495134

REGISTERED

Sep 21, 2021

Owner

Applicant

Invite Health, Inc.

Entity

Corporation

State

Address

900 Shames Drive, Westbury, NY, 11590

Country

Attorney

NameLindsey S. Leibowitz

Law firm

Lindsey S. Leibowitz FEDER KASZOVITZ LLP

Address

845 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY 10022-6601, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 26, 2020

Serial Number90278183

Registration No.6495134

Registration DateSep 21, 2021

Status DateSep 21, 2021

Published for OppositionMay 11, 2021

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 01, 2020

First use in commerce: Nov 01, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

REGISTERED-PRINCIPAL REGISTER

Sep 21, 2021

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 14, 2021

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 13, 2021

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Aug 03, 2021

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 02, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Jul 21, 2021

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jul 21, 2021

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 06, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 11, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 11, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 21, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 08, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 07, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 06, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 06, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 29, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 29, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Mar 29, 2021

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 29, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NON-FINAL ACTION WRITTEN

Mar 26, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 26, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 26, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 25, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 16, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 29, 2020

NEW APPLICATION ENTERED

RESVERATROL MAX HX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Invite Health, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Lindsey S. Leibowitz

Resources

Company